One Year of SARS-CoV-2 Evolution

Overview

Journal Cell Host Microbe

Publisher Cell Press

Specialties Infectious Diseases
Microbiology

Date 2021 Mar 7

PMID 33676588

Citations 45

Authors

Aiping Wu

Lulan Wang

Hang-Yu Zhou

Cheng-Yang Ji

Shang Zhou Xia

Yang Cao

Jing Meng

Xiao Ding

Sarah Gold

Taijiao Jiang

Genhong Cheng

Affiliations

Soon will be listed here.

Abstract

Since the outbreak of SARS-CoV-2, the etiologic agent of the COVID-19 pandemic, the viral genome has acquired numerous mutations with the potential to increase transmission. One year after its emergence, we now further analyze emergent SARS-CoV-2 genome sequences in an effort to understand the evolution of this virus.

Citing Articles

MOI is a comprehensive database collecting processed multi-omics data associated with viral infection.

Guo X, Zhao Y, You F Sci Rep. 2024; 14(1):14725.

PMID: 38926513 PMC: 11208532. DOI: 10.1038/s41598-024-65629-6.

Towards Understanding and Identification of Human Viral Co-Infections.

Wu H, Zhou H, Zheng H, Wu A Viruses. 2024; 16(5).

PMID: 38793555 PMC: 11126107. DOI: 10.3390/v16050673.

[Future of vaccination against SARS-CoV-2 infection].

Leonardo R Open Respir Arch. 2024; 3(3):100117.

PMID: 38620914 PMC: 8240445. DOI: 10.1016/j.opresp.2021.100117.

Evolutionary trajectory of diverse SARS-CoV-2 variants at the beginning of COVID-19 outbreak.

Lv J, Liu X, Pei Y, Song Z, Chen X, Hu S Virus Evol. 2024; 10(1):veae020.

PMID: 38562953 PMC: 10984623. DOI: 10.1093/ve/veae020.

Differentiating Cell Entry Potentials of SARS-CoV-2 Omicron Subvariants on Human Lung Epithelium Cells.

Katte R, Ao Y, Xu W, Han Y, Zhong G, Ghimire D Viruses. 2024; 16(3).

PMID: 38543757 PMC: 10975267. DOI: 10.3390/v16030391.

References

Plante J, Liu Y, Liu J, Xia H, Johnson B, Lokugamage K . Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2020; 592(7852):116-121. PMC: 8158177. DOI: 10.1038/s41586-020-2895-3. View

Korber B, Fischer W, Gnanakaran S, Yoon H, Theiler J, Abfalterer W . Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell. 2020; 182(4):812-827.e19. PMC: 7332439. DOI: 10.1016/j.cell.2020.06.043. View

Shrock E, Fujimura E, Kula T, Timms R, Lee I, Leng Y . Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science. 2020; 370(6520). PMC: 7857405. DOI: 10.1126/science.abd4250. View

Bosnjak B, Stein S, Willenzon S, Cordes A, Puppe W, Bernhardt G . Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods. Cell Mol Immunol. 2020; 18(4):936-944. PMC: 7604543. DOI: 10.1038/s41423-020-00573-9. View

Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes C, Finkin S . mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021; 592(7855):616-622. PMC: 8503938. DOI: 10.1038/s41586-021-03324-6. View

Starr T, Greaney A, Hilton S, Ellis D, Crawford K, Dingens A . Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell. 2020; 182(5):1295-1310.e20. PMC: 7418704. DOI: 10.1016/j.cell.2020.08.012. View

Grubaugh N, Petrone M, Holmes E . We shouldn't worry when a virus mutates during disease outbreaks. Nat Microbiol. 2020; 5(4):529-530. PMC: 7095397. DOI: 10.1038/s41564-020-0690-4. View

Yurkovetskiy L, Wang X, Pascal K, Tomkins-Tinch C, Nyalile T, Wang Y . Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant. Cell. 2020; 183(3):739-751.e8. PMC: 7492024. DOI: 10.1016/j.cell.2020.09.032. View

Poland G, Ovsyannikova I, Kennedy R . SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. Lancet. 2020; 396(10262):1595-1606. PMC: 7553736. DOI: 10.1016/S0140-6736(20)32137-1. View

10.

Hadfield J, Megill C, Bell S, Huddleston J, Potter B, Callender C . Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018; 34(23):4121-4123. PMC: 6247931. DOI: 10.1093/bioinformatics/bty407. View

11.

Shu Y, McCauley J . GISAID: Global initiative on sharing all influenza data - from vision to reality. Euro Surveill. 2017; 22(13). PMC: 5388101. DOI: 10.2807/1560-7917.ES.2017.22.13.30494. View

12.

van Dorp L, Richard D, Tan C, Shaw L, Acman M, Balloux F . No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nat Commun. 2020; 11(1):5986. PMC: 7688939. DOI: 10.1038/s41467-020-19818-2. View

13.

Greaney A, Starr T, Gilchuk P, Zost S, Binshtein E, Loes A . Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition. Cell Host Microbe. 2020; 29(1):44-57.e9. PMC: 7676316. DOI: 10.1016/j.chom.2020.11.007. View

14.

McCarthy K, Rennick L, Nambulli S, Robinson-McCarthy L, Bain W, Haidar G . Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science. 2021; 371(6534):1139-1142. PMC: 7971772. DOI: 10.1126/science.abf6950. View

15.

Wu F, Zhao S, Yu B, Chen Y, Wang W, Song Z . A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265-269. PMC: 7094943. DOI: 10.1038/s41586-020-2008-3. View